Berman Capital Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
Berman Capital Advisors's RGEN Position: Q3 2021 in Review
Berman Capital Advisors increased its Repligen (RGEN) stake by 97% in Q3 2021, buying an estimated $9.49K and bringing the position to 75 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #974.
Berman Capital Advisors first reported a position in RGEN in Q2 2020 and has held it in 6 quarters since. 479 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.
- Berman Capital Advisors held 75 shares of Repligen worth $21K as of Q3 2021.
- Berman Capital Advisors bought 37 Repligen shares in Q3 2021, an estimated $9.49K.
- Repligen made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #974 holding.
- Berman Capital Advisors first reported a position in Repligen in Q2 2020 and has held it in 6 quarters since.
- 479 funds tracked by Wall St. Rank held Repligen as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.